Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Human Mutation

• Publication date

  2003-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/HUMU.10260PMID 12955716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• RNA analysis of eight BRCA1 and BRCA2 unclassified variants identified in breast/ovarian cancer families from Spain

  2003cited by this paper
• Haplotype analysis of the BRCA2 9254delATCAT recurrent mutation in breast/ovarian cancer families from Spain

  2003cited by this paper
• BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic.

  2002cited by this paper
• Comprehensive analysis of 989 patients with breast or ovarian cancer provides BRCA1 and BRCA2 mutation profiles and frequencies for the German population

  2002cited by this paper
• Selective genetic screening in 250 Belgian breast and ovarian cancer families identifies BRCA1 or BRCA2 mutations in 20% of cases

  2002cited by this paper
• A comprehensive model for familial breast cancer incorporating BRCA1, BRCA2 and other genes

  2002cited by this paper
• Association between BRCA1 and BRCA2 mutations and cancer phenotype in Spanish breast/ovarian cancer families: Implications for genetic testing

  2002cited by this paper
• Variation in BRCA1 cancer risks by mutation position.

  2002cited by this paper
• Loss of heterozygosity analysis at the BRCA loci in tumor samples from patients with familial breast cancer

  2002cited by this paper
• Analysis of BRCA1 and BRCA2 in breast and breast/ovarian cancer families shows population substructure in the Iberian peninsula

  2002cited by this paper
• Variation in cancer risks, by mutation position, in BRCA2 mutation carriers.

  2001cited by this paper
• Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.

  2001cited by this paper
• Spanish family study on hereditary breast and/or ovarian cancer: analysis of the BRCA1 gene.

  2001cited by this paper
• BRCA2 mutation analysis of 87 Spanish breast/ovarian cancer families.

  2001cited by this paper
• Functional analysis of BRCA1 C-terminal missense mutations identified in breast and ovarian cancer families.

  2001cited by this paper
• The R71G BRCA1 is a founder Spanish mutation and leads to aberrant splicing of the transcript

  2001cited by this paper
• Spanish family study on hereditary breast and/or ovarian cancer: Analysis of the BRCA1 gene

  2001cited by this paper
• "Other" breast cancer susceptibility genes: searching for more holy grail.

  2001cited by this paper
• Molecular analysis of the BRCA1 and BRCA2 genes in 32 breast and/or ovarian cancer Spanish families

  2000cited by this paper
• Screening for genomic rearrangements in families with breast and ovarian cancer identifies BRCA1 mutations previously missed by conformation-sensitive gel electrophoresis or sequencing.

  2000cited by this paper
• A highly accurate, low cost test forBRCA1 mutations

  1999cited by this paper
• BRCA1 mutation analysis in 83 Spanish breast and breast/ovarian cancer families

  1999cited by this paper
• Prevalence of BRCA1 and BRCA2 Jewish mutations in Spanish breast cancer patients

  1999cited by this paper
• Genetic analysis of BRCA1 function in a defined tumor cell line.

  1999cited by this paper
• Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study.

  1998cited by this paper
• Identification of the 185delAG BRCA1 mutation in a Spanish Gypsy population

  1998cited by this paper
• BRCA1 mutations and breast cancer in the general population: analyses in women before age 35 years and in women before age 45 years with first-degree family history.

  1998cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

  1997cited by this paper
• BRCA2 in American families with four or more cases of breast or ovarian cancer: recurrent and novel mutations, variable expression, penetrance, and the possibility of families whose cancer is not attributable to BRCA1 or BRCA2.

  1997cited by this paper
• Population genetics of BRCA1 and BRCA2.

  1997cited by this paper
• Mutations in BRCA1 and BRCA2 in breast cancer families: are there more breast cancer-susceptibility genes?

  1997cited by this paper
• Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

  1997cited by this paper
• Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.

  1997cited by this paper
• Human, canine and murine BRCA1 genes: sequence comparison among species.

  1996cited by this paper
• Mutation analysis in the BRCA2 gene in primary breast cancers

  1996cited by this paper
• Rapid detection of BRCA1 mutations by the protein truncation test

  1995cited by this paper
• Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

  1995cited by this paper
• The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

  1995cited by this paper
• Familial male breast cancer is not linked to the BRCA1 locus on chromosome 17q

  1994cited by this paper
• Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

  1994cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper

• Prevalence and clinical impact of germline pathogenic variants in breast cancer: a descriptive large single-center study

  2025cites this paper
• Considerations for hereditary breast and ovarian cancer syndrome molecular diagnosis: experience from the clinical practice

  2025cites this paper
• Molecular analysis of BRCA1 and BRCA2 genes in La Rioja (Spain): five new variants

  2024influential citation
• The BRCA mutation spectrum among breast and ovarian cancers in India: highlighting the need to screen BRCA1 185delAG among South Indians

  2024cites this paper
• Landscape of germline BRCA1/BRCA2 variants in breast and ovarian cancer in Peru

  2023cites this paper
• BRCA1/2 potential founder variants in the Jordanian population: an opportunity for a customized screening panel

  2023influential citation
• The c.156_157insAlu rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal

  2023cites this paper
• Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective

  2022cites this paper
• Using species richness calculations to model the global profile of unsampled pathogenic variants: Examples from BRCA1 and BRCA2

  2022cites this paper
• A Large Case-Control Study Performed in Spanish Population Suggests That RECQL5 Is the Only RECQ Helicase Involved in Breast Cancer Susceptibility

  2022cites this paper
• Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa

  2021cites this paper
• Navigating Multi-Scale Cancer Systems Biology Towards Model-Driven Clinical Oncology and Its Applications in Personalized Therapeutics

  2021cites this paper
• Identification of BRCA2 Cis Double Heterozygous Breast Cancer Cases Using Whole Exome Sequencing: Phenotypic Expression and Impact on Personalized Oncology

  2021cites this paper
• A novel frequent BRCA1 recurrent variant c.5117G > A (p.Gly1206Glu) identified after 20 years of BRCA1/2 research in the Baltic region: cohort study and literature review

  2021influential citation
• Differences in Ovarian and Other Cancers Risks by Population and BRCA Mutation Location

  2021cites this paper
• High-resolution melting analysis for rapid screening of and Spanish mutations

  2020cites this paper
• High-resolution melting analysis for rapid screening of and Spanish mutations

  2020cites this paper
• Evaluation of the interacting genes and in familial breast cancer susceptibility

  2020cites this paper
• Spectrum of point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families

  2020cites this paper
• Novel and recurrent BRCA1/BRCA2 germline mutations in patients with breast/ovarian cancer: a series from the south of Tunisia

  2020cites this paper
• Molecular Spectrum of Germline BRCA1 and BRCA2 Mutation in a Cohort of Indian Cancer Patients: A Report from Reference Laboratory

  2020cites this paper
• Space-time analysis of ovarian cancer mortality rates by age groups in spanish provinces (1989–2015)

  2020cites this paper
• Spectrum of Germline BRCA1 and BRCA2 Variants Identified in 2351 Ovarian and Breast Cancer Patients Referring to a Reference Cancer Hospital of Rome

  2020cites this paper
• Establishing a Program for Young Women at High Risk for Breast Cancer

  2020cites this paper
• Non-BRCA1/2 Variants Detected in a High-Risk Chilean Cohort With a History of Breast and/or Ovarian Cancer

  2019cites this paper
• Characterization of BRCA1 and BRCA2 genetic variants in a cohort of Bahraini breast cancer patients using next‐generation sequencing

  2019cites this paper
• Human Mutation

  2019cites this paper
• Epidemiology, Risk Factors, and Prevention

  2019cites this paper
• RECQL5: Another DNA helicase potentially involved in hereditary breast cancer susceptibility

  2019cites this paper
• Mutational analysis of BRCA1 and BRCA2 genes in women with familial breast cancer from different regions of Colombia

  2019cites this paper
• Genetic epidemiology of ovarian cancer in the 22 Arab countries: A systematic review.

  2019cites this paper
• A Recurrent BRCA2 Mutation Explains the Majority of Hereditary Breast and Ovarian Cancer Syndrome Cases in Puerto Rico

  2018cites this paper
• Análisis de la prevalencia de las mutaciones BRCA1 y BRCA2 en Colombia en el período 2014-2018

  2018cites this paper
• Hereditary breast and ovarian cancer in Andalusian families: a genetic population study

  2018cites this paper
• Portadoras de mutaciones en BRCA1 y 2 en familias de alto riesgo del área de Ciudad Real (España): prevalencia mutacional y características clínico-patológicas del cáncer de mama y ovario

  2018cites this paper
• Medical Management of Breast Cancer in BRCA Mutation Carriers

  2017cites this paper
• Prevalence and Penetrance of BRCA1 and BRCA2 Germline Mutations in Colombian Breast Cancer Patients

  2017cites this paper
• Impact of germline and somatic BRCA1/2 mutations: tumor spectrum and detection platforms

  2017cites this paper
• Almost 2% of Spanish breast cancer families are associated to germline pathogenic mutations in the ATM gene

  2017cites this paper
• Familial Gastrointestinal Stromal Tumor with Germline KIT Mutations Accompanying Hereditary Breast and Ovarian Cancer Syndrome.

  2017cites this paper
• Molecular characterization and clinical interpretation of BRCA1/BRCA2 variants in families from Murcia (south-eastern Spain) with hereditary breast and ovarian cancer: clinical–pathological features in BRCA carriers and non-carriers

  2017cites this paper
• Search for new susceptibility genes in hereditary BRCAX families with an apparent recessive pattern of inheritance using Whole Exome Sequencing

  2017cites this paper
• Mutational analysis of BRCA1 and BRCA2 genes in Peruvian families with hereditary breast and ovarian cancer

  2017cites this paper
• Individualized Novel Therapies for Patients with Tumor Suppressor Genes BRCA1 and BRCA2 Mutated Epithelial Ovarian Cancer

  2016cites this paper
• Prevalence of Hispanic BRCA1 and BRCA2 mutations among hereditary breast and ovarian cancer patients from Brazil reveals differences among Latin American populations.

  2016cites this paper
• The Impact of Evolutionary Driving Forces on Human Complex Diseases: A Population Genetics Approach

  2016cites this paper
• PCR- based quantification of exon 21 in BRCA2 gene in Breast cancer patients in Erbil province

  2016cites this paper
• Investigating the effect of 28 BRCA1 and BRCA2 mutations on their related transcribed mRNA

  2016cites this paper
• Germline missense pathogenic variants in the BRCA1 BRCT domain, p.Gly1706Glu and p.Ala1708Glu, increase cellular sensitivity to PARP inhibitor olaparib by a dominant negative effect.

  2016cites this paper
• BRCA1 and BRCA2 mutations in males with familial breast and ovarian cancer syndrome. Results of a Spanish multicenter study

  2015cites this paper
• Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico

  2015cites this paper
• Two novel frameshift mutations in BRCA2 gene detected by next generation sequencing in a survey of Spanish patients of breast cancer

  2015cites this paper
• The prevalence of BRCA1 and BRCA2 mutations among young Mexican women with triple-negative breast cancer

  2015cites this paper
• CONSTITUTIVE OGG1 VARIANT TOGETHER WITH BRCA MUTATIONS DISPLAY ACCELERATED TELOMERE SHORTENING

  2015cites this paper
• Corrective Measures of Denaturing Gradient Gel Electrophoresis Limitations

  2015cites this paper
• A Unified Framework for the Prioritization of Variants of Uncertain Significance in Hereditary Breast and Ovarian Cancer Patients

  2015cites this paper
• Pathogenicity evaluation of BRCA1 and BRCA2 unclassified variants identified in Portuguese breast/ovarian cancer families.

  2014cites this paper
• Functional Assays for Analysis of Variants of Uncertain Significance in BRCA2

  2014cites this paper
• Breast cancer survival of Hispanic women in the USA is influenced by country of origin

  2014cites this paper
• Impact of chemotherapy on telomere length in sporadic and familial breast cancer patients

  2014cites this paper
• Screening for common mutations in BRCA1 and BRCA2 genes: interest in genetic testing of Tunisian families with breast and/or ovarian cancer.

  2014cites this paper
• Hereditary Breast Cancer: Clinical, Pathological and Molecular Characteristics

  2014cites this paper
• About 1% of the breast and ovarian Spanish families testing negative for BRCA1 and BRCA2 are carriers of RAD51D pathogenic variants

  2014cites this paper
• Short telomeres are frequent in hereditary breast tumors and are associated with high tumor grade

  2013cites this paper
• Mutational analysis of BRCA1 and BRCA2 in hereditary breast and ovarian cancer families from Asturias (Northern Spain)

  2013influential citation
• Classifications within Molecular Subtypes Enables Identification of BRCA1/BRCA2 Mutation Carriers by RNA Tumor Profiling

  2013cites this paper
• The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins.

  2013cites this paper
• Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence

  2013cites this paper
• ANALISIS DE MUTACIONES EN EL GEN BRCA1 EN MUJERES CON CANCER DE MAMA HEREDOFAMILIAR ATENDIDAS EN LOS SERVICIOS DE ONCOLOGIA DE BUCARAMANGA

  2013cites this paper
• For Peer Review The highly prevalent BRCA2 mutation c.2808_2811del (3036delACAA) is located in a mutational hotspot and has multiple origins.

  2013cites this paper
• Novel and recurrent BRCA1/BRCA2 mutations in early onset and familial breast and ovarian cancer detected in the Program of Genetic Counseling in Cancer of Valencian Community (eastern Spain). Relationship of family phenotypes with mutation prevalence

  2013cites this paper
• Characterization of four novel BRCA2 large genomic rearrangements in Spanish breast/ovarian cancer families: review of the literature, and reevaluation of the genetic mechanisms involved in their origin

  2012cites this paper
• Hereditary Breast Cancer: Practical Pursuit for Clinical Translation

  2012cites this paper
• Analysis of 30 Putative BRCA1 Splicing Mutations in Hereditary Breast and Ovarian Cancer Families Identifies Exonic Splice Site Mutations That Escape In Silico Prediction

  2012cites this paper
• Detection of genomic variations in BRCA1 and BRCA2 genes by long-range PCR and next-generation sequencing.

  2012cites this paper
• Características epidemiológicas del cáncer de mama y ovario hereditario y del cáncer de mama esporádico en una muestra de la población del ISSSTE

  2012cites this paper
• Predominance of pathogenic missense variants in the RAD51C gene occurring in breast and ovarian cancer families.

  2012cites this paper
• Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members

  2012cites this paper
• Family History and Breast Cancer Hormone Receptor Status in a Spanish Cohort

  2012cites this paper
• Identification of the prevalent BRCA1 and BRCA2 mutations in the female population of Puerto Rico.

  2012cites this paper
• Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members

  2011cites this paper
• A novel mutation in BRCA1 linked to breast and ovarian cancer and a genotype-phenotype correlation.

  2011cites this paper
• Comprehensive genetic characterization of hereditary breast/ovarian cancer families from Slovakia

  2011influential citation
• Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population

  2011cites this paper
• Transcriptional characteristics of familial non‐BRCA1/BRCA2 breast tumors

  2011cites this paper
• A novel mutation in BRCA 1 linked to breast and ovarian cancer and a genotype-phenotype correlation

  2011cites this paper
• Consejo genético en el cáncer de mama y ovario. ¿Y luego qué?

  2011cites this paper
• BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast–ovarian cancer families. Identification of novel mutations and unclassified variants

  2011cites this paper
• Avaliação da patogenicidade de mutações germinativas de significado desconhecido nos genes BRCA1 e BRCA2 em famílias portuguesas.

  2011cites this paper
• Estudo de mutações no gene BRCA na população Ashkenazi e não Ashkenazi com histórico para câncer de mama e/ou ovário.

  2011cites this paper
• Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA 1 / BRCA 2 databases

  2011cites this paper
• A HRM-based screening method detects RAD51C germ-line deleterious mutations in Spanish breast and ovarian cancer families

  2011cites this paper
• Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families

  2011cites this paper
• Genetic Anticipation Is Associated with Telomere Shortening in Hereditary Breast Cancer

  2011cites this paper
• Genomic rearrangements of the BRCA1 gene in Chilean breast cancer families: an MLPA analysis

  2011cites this paper
• Description and analysis of genetic variants in French hereditary breast and ovarian cancer families recorded in the UMD-BRCA1/BRCA2 databases

  2011cites this paper
• Founder BRCA 1 / 2 mutations in the Europe : implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• BRCA1 5272‐1G>A and BRCA2 5374delTATG are founder mutations of high relevance for genetic counselling in breast/ovarian cancer families of Spanish origin

  2010cites this paper
• Founder BRCA1/2 mutations in the Europe: implications for hereditary breast-ovarian cancer prevention and control

  2010cites this paper
• [Predictive ability of the BRCAPro model compared to nursing professionals in the selection of candidates for the genetic study of hereditary breast or ovarian cancer].

  2010cites this paper